title: [Development of angiogenesis inhibitory combination therapies for treatment of renal cell carcinoma].
authors.affiliation: Abteilung für Urologie und Kinderurologie, Urologische Universitätsklinik und Poliklinik Ulm, Prittwitzstrasse 43, 89075 Ulm. georg.bartsch@uniklinik-ulm.de
authors.forename: G
authors.initials: G
authors.lastname: Bartsch
authors.forename: K
authors.initials: K
authors.lastname: Eggert
authors.forename: S
authors.initials: S
authors.lastname: Soker
authors.forename: W
authors.initials: W
authors.lastname: Fiedler
authors.forename: E
authors.initials: E
authors.lastname: Laack
authors.forename: B G
authors.initials: BG
authors.lastname: Volkmer
authors.forename: J
authors.initials: J
authors.lastname: Gschwend
authors.forename: C
authors.initials: C
authors.lastname: Bokemeyer
authors.forename: R
authors.initials: R
authors.lastname: Hautmann
authors.forename: G
authors.initials: G
authors.lastname: Schuch
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D043168:Angiostatins / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000098:blood supply* / Q000188:drug therapy* / Q000532:radiotherapy; D043169:Endostatins / Q000627:therapeutic use; D006801:Humans; D007680:Kidney Neoplasms / Q000098:blood supply* / Q000188:drug therapy* / Q000532:radiotherapy; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D043169:Endostatins; D011993:Recombinant Fusion Proteins; D043168:Angiostatins